Researchers Mapped DNA-Protein Adducts Without Toxins
The new pDAIP-seq method reveals how cellular enzymes interact with genomic DNA in their natural state.
Updated on Oct. 2, 2026 in Biotech
Researchers developed pDAIP-seq, a technique designed to map endogenous protein-DNA covalent intermediates within human cells without the use of chemical poisons. This research-stage method provides a clearer picture of spontaneous DNA breaks by capturing genomic interactions that were previously only visible when stabilized by drugs.
Why it matters
Traditional profiling methods relied on camptothecin, a drug that artificially alters genomic distributions, obscuring the true behavior of DNA-protein complexes. By removing this requirement, pDAIP-seq enables scientists to observe the natural landscape of enzymes and their roles in DNA maintenance and instability.
The pDAIP-seq method utilizes protein-DNA adduct immunoprecipitation and sequencing to detect endogenous complexes, including TOP1cc, without stabilizing agents. It successfully mapped TOP2cc, TOP3cc, and SPO11-DNA intermediates in mouse testis and identified specific local DNA sequences as primary determinants for catalytic cleavage sites.
The details
The pDAIP-seq method works by immunoprecipitating—isolating specific proteins from a complex mixture using antibodies—protein-DNA covalent intermediates, followed by high-throughput sequencing. While previous approaches required camptothecin—a compound that locks topoisomerase enzymes onto DNA—to detect these adducts, this method captures them in their native, transient state. It revealed that TOP1cc, a complex of topoisomerase I bound to DNA, acts as a source of spontaneous DNA breaks. The researchers also extended the platform to detect TDP1, PARP1, and KU70-DNA adducts, broadening its utility for mapping genome-wide protein interactions.
Timeline
October 2, 2026: Article publication date.
The Tech Race
This development marks a significant shift from drug-stabilized mapping to direct observation of endogenous protein-DNA intermediates in human cells. It competes with and effectively supersedes legacy protocols that introduced external bias, allowing for a higher-fidelity understanding of enzymatic genomic architecture.
This methodology is currently a research-stage tool used primarily for genomic analysis in academic and clinical laboratory settings. Its adoption will likely refine how researchers screen for DNA-related therapies and diagnostic markers by providing data that reflects the cellular environment without drug interference.
The takeaway
The pDAIP-seq technique offers a more accurate map of genomic maintenance enzymes by eliminating the need for distortive chemical stabilizers. Researchers should monitor future studies for the application of this method to analyze how these protein-DNA adducts change in response to different environmental triggers or disease states.
Further reading
For more developments in genomic research tools, visit Biotech.
Source note: This article includes information reported by Biorxiv.
